Outcomes of malignant orbital tumors: a 22-year Norwegian single-center series - Takeaways - MDSpire

Outcomes of malignant orbital tumors: a 22-year Norwegian single-center series

  • By

  • Bendik Alvheim Sundfjord

  • Julie Selvik Bentzon

  • Signe Johnsen Landa

  • Svein Arthur Jensen

  • Dorota Goplen

  • Jon Espen Dale

  • Stein Lybak

  • Hans Olav Ueland

  • Eyvind Rødahl

  • June 24, 2026

  • 0 min

Share

  • 1

    The study included 76 patients with malignant orbital tumors, with a median age of 64 years at diagnosis.

  • 2

    Secondary invading tumors were the most common type, accounting for 46% of cases, followed by lymphoproliferative tumors at 24%.

  • 3

    Surgical removal was performed in 55% of patients, with 55% of those undergoing exenteration.

  • 4

    The overall disease-specific 5-year survival rate was 59%, with significant variations among tumor subgroups.

  • 5

    The findings align closely with international literature, indicating that high-quality care is feasible at a low-volume center.

Original Source(s)

Outcomes of malignant orbital tumors: a 22-year Norwegian single-center series

  • by Bendik Alvheim Sundfjord, Julie Selvik Bentzon, Signe Johnsen Landa, Svein Arthur Jensen, Dorota Goplen, Jon Espen Dale, Stein Lybak, Hans Olav Ueland, Eyvind Rødahl

  • June 24, 2026

Related Content

Gitogenin impedes tumorigenesis in hepatocellular carcinoma via NUAK2/NF-κB axis

Identification and validation of biomarkers related to mismatch repair for prognosis prediction in glioma

Metastatic extramammary Paget’s disease successfully treated by trastuzumab deruxtecan: a rare case report